Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: 938858 / Symbol: MDCO / Name: Medicines / Stock / Pharmaceuticals / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Medicines Co. Stock

Pros and Cons of Medicines Co. in the next few years

Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Medicines Co. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Medicines Co. - - - - - - -
Repligen Corp. 1.720% -4.344% 17.387% 13.622% -13.241% -5.710% -28.139%
Opko Health Inc. -1.500% 3.150% 9.167% 17.573% 20.161% -31.103% -62.182%
Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. 4.400% 4.403% -1.190% -11.230% -15.306% -38.060% -36.641%

Comments

Prediction Sell
Perf. (%) 46.60%
Target price
Change
Ends at 26.12.19

Sell beendet
Show more

Sell Medicines Co.
Show more

News

Revolution Medicines Has a $40 Billion Market Cap and Generates No Revenue. Here's Why That's Not Absurd.: https://g.foolcdn.com/editorial/images/876559/research-scientists-drugs-pharma-biotech.jpg
Revolution Medicines Has a $40 Billion Market Cap and Generates No Revenue. Here's Why That's Not Absurd.

Most clinical-stage biotechs are small-cap companies. That makes sense. Not only can it take years -- sometimes over a decade -- to develop novel medicines, but it is also a very risky endeavor

This Little-Known Biotech Just Delivered a Bigger IPO Pop Than SpaceX -- and Regeneron Is Already Invested: https://g.foolcdn.com/editorial/images/874970/a-young-scientist-recording-her-findings-on-a-tablet.jpg
This Little-Known Biotech Just Delivered a Bigger IPO Pop Than SpaceX -- and Regeneron Is Already Invested

The June 10 IPO of Parabilis Medicines (NASDAQ: PBLS) closed up 58% from its $20 offer price. Two days later, Space Exploration Technologies, the largest IPO in history, finished its debut up just

Why Eli Lilly Stock Jumped to a New All-Time High Today: https://g.foolcdn.com/editorial/images/876632/healthcare-gettyimages-660133306.jpg
Why Eli Lilly Stock Jumped to a New All-Time High Today

Shares of Eli Lilly (NYSE: LLY) climbed to a record high on Friday, following several promising developments for the medicine maker.

Image source: Getty Images.

The European Medicines Agency's